scispace - formally typeset
P

Petteri Hintsanen

Researcher at University of Helsinki

Publications -  16
Citations -  772

Petteri Hintsanen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Phosphoproteomics & Subgraph isomorphism problem. The author has an hindex of 12, co-authored 16 publications receiving 590 citations. Previous affiliations of Petteri Hintsanen include Helsinki Institute for Information Technology.

Papers
More filters
Journal ArticleDOI

Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis.

TL;DR: A systematic evaluation of target selectivity profiles across three recent large-scale biochemical assays of kinase inhibitors and further compared these standardized bioactivity assays with data reported in the widely used databases ChEMBL and STITCH revealed relative benefits and potential limitations among the bioactivity types.
Book ChapterDOI

Link discovery in graphs derived from biological databases

TL;DR: In this paper, the authors propose a method for link discovery in biological databases, i.e., for prediction and evaluation of implicit or previously unknown connections between biological entities and concepts, and propose measures for link goodness that are based on three factors: edge reliability, relevance, and rarity.
Journal ArticleDOI

Finding reliable subgraphs from large probabilistic graphs

TL;DR: Two new heuristics for solving the most reliable subgraph extraction problem on large, undirected probabilistic graphs are proposed and results indicate that the methods scale much better to large input graphs, both computationally and in terms of the quality of the result.
Journal ArticleDOI

Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages

TL;DR: The first comprehensive phosphoproteome characterization of influenza A virus infection in primary human macrophages is provided, and evidence that cyclin-dependent kinases represent potential therapeutic targets for more effective treatment of influenza infections is provided.